Raymond James Financial Inc Bio Rad Laboratories, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 15,581 shares of BIO stock, worth $5.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,581Holding current value
$5.38 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
458Shares Held
17.7MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$659 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$536 Million0.01% of portfolio
-
Veritas Asset Management LLP977KShares$337 Million3.36% of portfolio
-
Van Eck Associates Corp723KShares$250 Million0.3% of portfolio
-
First Eagle Investment Management, LLC713KShares$246 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.51B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...